Replimune (REPL) Exchange Rate Effect (2017 - 2026)
Replimune (REPL) reported Exchange Rate Effect of $50000.0 for Q1 2026, down 88.64% on a YoY basis from $440000.0 in Q1 2025, and down 95.17% sequentially from $1.0 million in Q4 2025.
Replimune (REPL) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Exchange Rate Effect data on file, last reported at $50000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 88.64% year-over-year to $50000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 253.02% YoY), and the FY2026 full-year result was $1.1 million, up 253.02% from the prior year.
- Exchange Rate Effect fell to $50000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.4 million in Q3 2022 to a low of -$4.5 million in Q1 2023.
- A 5-year average of $84058.8 and a median of $13000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 2591.8% in 2025, while the deepest fall reached 4517.14% in 2025.
- Tracing REPL's Exchange Rate Effect over 5 years: stood at -$8000.0 in 2022, then sank by 237.5% to -$27000.0 in 2023, then slumped by 459.26% to -$151000.0 in 2024, then jumped by 786.09% to $1.0 million in 2025, then slumped by 95.17% to $50000.0 in 2026.
- Business Quant data shows REPL's Exchange Rate Effect at $50000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | 440,000.00 |
| Mar 31, 2025 | 440,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |